CONFIDENTIAL February 14, 2013Acorda Therapeutics Inc • May 10th, 2013 • Biological products, (no disgnostic substances) • New York
CONFIDENTIAL Addendum Number 3 to Collaboration and License Agreement and to Supply AgreementSupply Agreement • May 10th, 2013 • Acorda Therapeutics Inc • Biological products, (no disgnostic substances)
This Addendum Number 3 to Collaboration and License Agreement and to Supply Agreement (“Addendum Number 3”) is entered into February 14, 2013 (“Addendum Number 3 Effective Date”), by and between Acorda Therapeutics, Inc. (“Acorda”) and Biogen Idec International GmbH (“Licensee”). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the License Agreement (as defined below).
